Search Results - "Borba, HH"

Refine Results
  1. 1
  2. 2
  3. 3

    Effectiveness and Cost-Effectiveness of Triple Therapy With Telaprevir and Boceprevir for Chronic Hepatitis C: A Decision Analysis from The Perspective of The Brazilian Public Health System by Borba, HH, Rochau, U, Wiens, A, Sroczynski, G, Siebert, U, Pontarolo, R

    Published in Value in health (01-10-2017)
    “…OBJECTIVES: To perform a cost-effectiveness analysis comparing the regimens peginterferon plus ribavirin (peglFN/RBV), boceprevir (BOC) plus peglFN/RBV,…”
    Get full text
    Journal Article
  4. 4
  5. 5
  6. 6

    Genotype and Liver Fibrosis Distribution Among Hepatitis C Patients in A Single Center in the South of Brasil: A Cross-Sectional Study by Borba, HH, Wiens, A, Ivantes, CA, Santos, JC, Tawil, FB, Pontarolo, R

    Published in Value in health (01-10-2017)
    “…OBJECTIVES: This study aimed to describe the genotype distribution of hepatitis C virus (HCV), as well as the liver fibrosis stages according to the…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13

    TREATMENT INTERRUPTION OF BIOLOGICAL DRUGS IN RHEUMATOID ARTHRITIS: AN ASSESSMENT OF CASE-REPORTSA935 by Wiens, A, Borba, HH, Leonart, L, Ferreira, VL, Steimbach, LM, Tonin, FS, Araújo, AG, Piazza, T, Pontarolo, R

    Published in Value in health (01-10-2017)
    “…OBJECTIVES: The aim of this study was to evaluate the interruptions of treatment with biological drugs, due to adverse events, in patients with rheumatoid…”
    Get full text
    Journal Article
  14. 14

    Characterization Of Worldwide Publications On Network Meta-Analysis: A Systematic Review by Tonin, FS, Borba, HH, Steimbach, LM, Mendes, AM, Fernandez-Llimos, F, Pontarolo, R

    Published in Value in health (01-10-2017)
    “…OBJECTIVES: There is an evident increase of publications of systematic reviews with network meta-analyses (NMA) to compare several medical interventions…”
    Get full text
    Journal Article
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20